Ann: Peak Receives CAD$130K Initial Purchase Order From WeedMD, page-11

Not sure people fully understand the importance of Peak:

Firstly it allows AGH to produce its own finished medicinal Cannabis products for sale into our own expanding territories, greatly decreasing Cogs and increasing margins for those products sold, but without any of the downside risk and capital expenditure of being responsible for the growing of the cannabis itself. We can essentially farm out the raw material supply side and focus on producing high margin products which we then sell via our distribution partners into our various expanding territories (whilst also keeping valuable patient outcome records via Concierge).

2nd we can contract produce finished consumables for the “non medicinal” market - beverages/lollies/tinctures... for other companies. Again de risking our proposition as we are not responsible for growing the biological matter, the sales or the marketing - just the production, BUT we can still benefit from meaningful revenues and gain valuable insight into what is selling - and produce our own brand of “it” further down the line if we so wished...

IMO Peak will soon be an absolute goldmine once there is wider acceptance of Cannabis products and we have the first mover advantage to be able to capitalise on that.

DYOR IMO